Not available outside of the UK & Ireland.
Biochem/physiol Actions
DDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, and enhances the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: